As Microsoft (MSFT) Stock Value Declined, Shareholder Chesapeake Asset Management Has Trimmed by $519,270 Its Holding; Inovio Pharmaceuticals (INO) Holder Round Table Services Increased Holding by $1.05 Million as Stock Price Declined

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Logo

Chesapeake Asset Management Llc decreased its stake in Microsoft Corp (MSFT) by 9.02% based on its latest 2018Q3 regulatory filing with the SEC. Chesapeake Asset Management Llc sold 4,555 shares as the company’s stock declined 1.64% with the market. The hedge fund held 45,929 shares of the prepackaged software company at the end of 2018Q3, valued at $5.25M, down from 50,484 at the end of the previous reported quarter. Chesapeake Asset Management Llc who had been investing in Microsoft Corp for a number of months, seems to be less bullish one the $781.05 billion market cap company. The stock decreased 1.04% or $1.07 during the last trading session, reaching $101.73. About 14.00 million shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 30.43% since January 14, 2018 and is uptrending. It has outperformed by 30.43% the S&P500. Some Historical MSFT News: 07/05/2018 – Microsoft Co-Founder Bill Gates backed Warren Buffett’s decision to up Berkshire’s stake in Apple, calling it an “amazing” company; 16/05/2018 – David S. Joachim: SCOOP: Microsoft is planning to release a low-cost tablet line to rival Apple’s iPad; 10/05/2018 – Bill Gates struggled to quit this bad habit to make sure Microsoft was a success; 16/04/2018 – Docutech’s Solex eVault Receives Fannie Mae Approval, MERS® eRegistry Certification; 07/05/2018 – MSFT: Microsoft 365 sounds like it’s taking over Windows 10 as the operating system, or rather subsuming it as Windows becomes part of the cloud and edge. #MSBuild2018 – ! $MSFT; 30/04/2018 – Lightspeed Venture Partners Says Microsoft Chairman John Thompson Joining as a Venture Partner; 10/04/2018 – Atrio Systems Announces Rebranding to NuSoft Solutions; 19/03/2018 – The Register: Breaking up is hard to do: More drama with #Airbus, new bae Google and Microsoft. Apparently Redmond still has a; 17/04/2018 – Ionic Security and Microsoft collaborate to simplify risk management and accelerate enterprise cloud adoption through Microsoft Azure Information Protection; 07/03/2018 – Tencent’s Pony Ma overtakes Wanda’s Wang as Asia’s richest

Round Table Services Llc increased its stake in Inovio Pharmaceuticals Inc (INO) by 162.08% based on its latest 2018Q3 regulatory filing with the SEC. Round Table Services Llc bought 209,891 shares as the company’s stock declined 4.77% with the market. The institutional investor held 339,391 shares of the health care company at the end of 2018Q3, valued at $1.89 million, up from 129,500 at the end of the previous reported quarter. Round Table Services Llc who had been investing in Inovio Pharmaceuticals Inc for a number of months, seems to be bullish on the $439.55M market cap company. The stock decreased 4.75% or $0.23 during the last trading session, reaching $4.61. About 379,672 shares traded. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) has risen 18.49% since January 14, 2018 and is uptrending. It has outperformed by 18.49% the S&P500. Some Historical INO News: 24/05/2018 – Inovio Pharma: Kate Broderick Promoted to Vice President, Preclinical Research & Development; 14/03/2018 – Inovio Pharmaceuticals 4Q Loss/Shr 24c; 17/05/2018 – REG-INNATE PHARMA : Preliminary activity observed of the combination of monalizumab and durvalumab in patients with colorectal cancer; 20/03/2018 – lnovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China; 14/03/2018 – lnovio’s DNA Immunotherapy Demonstrates Immune Response Results Key in Treating Chronic Hepatitis B Infection; 24/05/2018 – lnovio Boosts Leadership Focused on Partnership and Grant Funding By Appointing Two New VPs for Business Development and R&D; 02/04/2018 – Inovio at HC Wainwright Global Biotechnology Conference Apr 9; 23/03/2018 – INNATE PHARMA SA – PARTNER MEDIMMUNE EXPANDS COLORECTAL CANCER PATIENT COHORT IN ONGOING PHASE l TRIAL EVALUATING MONALIZUMAB IN COMBINATION WITH IMFINZI® (DURVALUMAB); 14/03/2018 – INOVIO 4Q LOSS/SHR 24C, EST. LOSS/SHR 30C; 22/04/2018 – DJ Inovio Pharmaceuticals Inc, Inst Holders, 1Q 2018 (INO)

Among 8 analysts covering Inovio Pharmaceuticals (NASDAQ:INO), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Inovio Pharmaceuticals had 46 analyst reports since August 10, 2015 according to SRatingsIntel. The stock of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) has “Buy” rating given on Friday, October 6 by H.C. Wainwright. Zacks downgraded the shares of INO in report on Friday, August 14 to “Hold” rating. The firm has “Neutral” rating by PiperJaffray given on Thursday, March 16. The firm has “Buy” rating given on Thursday, October 5 by Stifel Nicolaus. The stock of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) has “Buy” rating given on Tuesday, November 27 by H.C. Wainwright. As per Thursday, June 1, the company rating was maintained by Maxim Group. The firm has “Buy” rating given on Friday, June 2 by H.C. Wainwright. The stock has “Buy” rating by Aegis Capital on Thursday, June 1. The stock of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) earned “Buy” rating by H.C. Wainwright on Thursday, March 15. The rating was maintained by Maxim Group on Thursday, June 8 with “Buy”.

More notable recent Inovio Pharmaceuticals, Inc. (NASDAQ:INO) news were published by: Nasdaq.com which released: “Inovio Pharmaceuticals Initiates Dosing in HIV Vaccine Study – Nasdaq” on August 16, 2018, also Nasdaq.com with their article: “Why Inovio Pharmaceuticals, Inc. Stock Is Soaring Today – Nasdaq” published on October 02, 2018, Streetinsider.com published: “Inovio Pharma (INO) Says its MERS Vaccine Generates High Levels of Antibodies and Induces Broad-based T Cell Responses in Phase 1 Study – StreetInsider.com” on June 27, 2018. More interesting news about Inovio Pharmaceuticals, Inc. (NASDAQ:INO) were released by: Globenewswire.com and their article: “Inovio Successfully Develops First DNA-Encoded Monoclonal Antibody (dMAbâ„¢) Checkpoint Inhibitor and Demonstrates Tumor Shrinkage in Preclinical Studies – GlobeNewswire” published on October 08, 2018 as well as Globenewswire.com‘s news article titled: “Inovio Presents Progression Free Survival & PSA Doubling Time Improvements in Prostate Cancer Patients Treated with INO-5150 – GlobeNewswire” with publication date: October 22, 2018.

Round Table Services Llc, which manages about $845.52 million and $292.64 million US Long portfolio, decreased its stake in Ishares Tr (IJR) by 63,783 shares to 36,869 shares, valued at $3.22M in 2018Q3, according to the filing. It also reduced its holding in Ishares Tr (IWB) by 24,278 shares in the quarter, leaving it with 66,490 shares, and cut its stake in Vanguard Tax Managed Intl Fd (VEA).

Since August 31, 2018, it had 0 insider purchases, and 10 selling transactions for $54.07 million activity. Nadella Satya sold $21.70M worth of stock. 2,000 shares valued at $214,363 were sold by BROD FRANK H on Monday, November 5. Hogan Kathleen T also sold $4.45M worth of Microsoft Corporation (NASDAQ:MSFT) on Friday, August 31. Hood Amy sold $13.09 million worth of stock.

Analysts await Microsoft Corporation (NASDAQ:MSFT) to report earnings on January, 30. They expect $1.09 EPS, up 13.54% or $0.13 from last year’s $0.96 per share. MSFT’s profit will be $8.37 billion for 23.33 P/E if the $1.09 EPS becomes a reality. After $1.14 actual EPS reported by Microsoft Corporation for the previous quarter, Wall Street now forecasts -4.39% negative EPS growth.

More notable recent Microsoft Corporation (NASDAQ:MSFT) news were published by: Seekingalpha.com which released: “AT&T And Microsoft: High-Yield Alternative Strategies For A Choppy Market – Seeking Alpha” on December 21, 2018, also Nasdaq.com with their article: “Microsoft (MSFT) Debuts Surface Go in India via Flipkart – Nasdaq” published on January 02, 2019, Nasdaq.com published: “Technology Sector Update for 12/28/2018: QTM, ABIL, QUIK, MSFT, AAPL, CSCO, IBM, GOOG – Nasdaq” on December 28, 2018. More interesting news about Microsoft Corporation (NASDAQ:MSFT) were released by: Nasdaq.com and their article: “After Hours Most Active for Dec 31, 2018 : FRC, T, QQQ, MSFT, PFE, SNV, D, GOV, CPB, CSCO, AAPL, MDLZ – Nasdaq” published on December 31, 2018 as well as Nasdaq.com‘s news article titled: “Technology Sector Update for 01/08/2019: GSUM, MEET, MSFT, AAPL, IBM, CSCO, GOOG – Nasdaq” with publication date: January 08, 2019.

Microsoft Corporation (NASDAQ:MSFT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.